AKTS financials
Aktis Oncology (AKTS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AKTS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $6.50M | $6.50M | -$74.68M | -$63.73M | -1.19 |
| 2024 | $1.49M | $1.49M | -$52.05M | -$43.98M | -1.26 |
| 2023 | $0.00 | $0.00 | -$34.79M | -$28.64M | -0.82 |
| 2022 | $0.00 | $0.00 | -$19.76M | -$17.93M | -0.51 |
- AKTS revenue was $6.50M in fiscal 2025, net income -$63.73M.
Updated 2026-11-03 12:36 UTC